Fem Ph
NDC Package 0813-0799-55

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Fem Ph is indicated as adjunctive therapy in those cases where restoration and maintenance of vaginal acidity is desirable. Marketed by Pharmics, Inc., this product is identified by NDC 0813-0799.

Identification & Billing

NDC Package Code
0813-0799-55
Package Description
50 g in 1 TUBE
Product Code
0813-0799
11-Digit Billing Format
00813079955
Billing Unit
GM - Billing unit of "gram" is used when a product is measured by its weight.
Units Per Package
50 GM
RxNorm Crosswalk
  • RxCUI: 1243480 - fem pH 0.9 % / 0.025 % Vaginal Gel
  • RxCUI: 1243480 - acetic acid 0.009 MG/MG / oxyquinoline sulfate 0.00025 MG/MG Vaginal Gel [Fem pH]
  • RxCUI: 1243480 - Fem pH (acetic acid 0.9 % / oxyquinoline sulfate 0.025 % ) Vaginal Gel
  • RxCUI: 543873 - acetic acid 0.9 % / oxyquinoline sulfate 0.025 % Vaginal Gel
  • RxCUI: 543873 - acetic acid 0.009 MG/MG / oxyquinoline sulfate 0.00025 MG/MG Vaginal Gel

Clinical Specifications

Proprietary Name
Fem Ph
Dosage Form
-
Usage Information
Fem pH is indicated as adjunctive therapy in those cases where restoration and maintenance of vaginal acidity is desirable.

Regulatory & Marketing

Labeler Name
Pharmics, Inc.
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
07-15-1999
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0813-0799-55 identifies a specific commercial package of 50 g in 1 tube of Fem Ph, labeled by Pharmics, Inc.. This product is billed per "GM" gram and contains an estimated amount of 50 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pharmics, Inc. on July 15, 1999. The current certification is valid through December 31, 2024.

How is this Pharmics, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00813079955. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 50 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0813-0799-55
11-Digit CMS (5-4-2)
00813-0799-55

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.